MCID: STR103
MIFTS: 43

Streptococcus Pneumonia

Categories: Infectious diseases, Respiratory diseases

Aliases & Classifications for Streptococcus Pneumonia

Summaries for Streptococcus Pneumonia

Disease Ontology : 12 A bacterial pneumonia has material basis in Streptococcus pneumoniae.

MalaCards based summary : Streptococcus Pneumonia is related to epiglottitis and irak4 deficiency. An important gene associated with Streptococcus Pneumonia is CYLD (CYLD Lysine 63 Deubiquitinase), and among its related pathways/superpathways are VEGF Pathway (Qiagen) and Development FGFR signaling pathway. The drugs Methylprednisolone and Methylprednisolone hemisuccinate have been mentioned in the context of this disorder. Affiliated tissues include testes, b cells and colon, and related phenotypes are Decreased viability and Decreased viability

Related Diseases for Streptococcus Pneumonia

Diseases related to Streptococcus Pneumonia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 213)
# Related Disease Score Top Affiliating Genes
1 epiglottitis 11.5
2 irak4 deficiency 11.3
3 myd88 deficiency 11.3
4 dacryocystitis 11.2
5 haemophilus influenzae 11.0
6 bacterial pneumonia 10.8
7 pneumonia 10.8
8 meningitis 10.8
9 otitis media 10.8
10 hemolytic-uremic syndrome 10.5
11 influenza 10.4
12 endophthalmitis 10.4
13 conjunctivitis 10.4
14 bacterial meningitis 10.4
15 arthritis 10.4
16 fasciitis 10.4
17 idiopathic severe pneumococcemia 10.4
18 septic arthritis 10.4
19 necrotizing fasciitis 10.4
20 endocarditis 10.3
21 pericarditis 10.3
22 pleural empyema 10.3
23 purpura 10.3
24 purpura fulminans 10.3
25 sinusitis 10.3
26 meningoencephalitis 10.3
27 pneumococcal meningitis 10.3
28 osteomyelitis 10.2
29 cellulitis 10.2
30 tetralogy of fallot 10.2
31 legionnaires' disease 10.2
32 keratitis, hereditary 10.1
33 lung abscess 10.1
34 trachoma 10.1
35 epidural abscess 10.1
36 diphtheria 10.1
37 aortitis 10.1
38 pulmonary disease, chronic obstructive 10.1
39 polyarteritis nodosa, childhood-onset 10.1
40 hepatitis 10.1
41 tetanus 10.1
42 bronchitis 10.1
43 peritonitis 10.1
44 systemic lupus erythematosus 10.1
45 myeloma, multiple 10.1
46 metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration 10.1
47 pelvic inflammatory disease 10.1
48 bacterial infectious disease 10.1
49 appendicitis 10.1
50 vasculitis 10.1

Graphical network of the top 20 diseases related to Streptococcus Pneumonia:



Diseases related to Streptococcus Pneumonia

Symptoms & Phenotypes for Streptococcus Pneumonia

GenomeRNAi Phenotypes related to Streptococcus Pneumonia according to GeneCards Suite gene sharing:

27 (show all 12)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-2 9.96 DGKE
2 Decreased viability GR00221-A-1 9.96 CYLD DGKE MAPK13 PRKCE
3 Decreased viability GR00221-A-2 9.96 CYLD DGKE MAPK13
4 Decreased viability GR00221-A-3 9.96 DGKE MAPK13
5 Decreased viability GR00221-A-4 9.96 PRKCE
6 Decreased viability GR00240-S-1 9.96 DGKE
7 Decreased viability GR00301-A 9.96 CYLD DGKE
8 Decreased viability GR00342-S-2 9.96 DGKE
9 Decreased viability GR00342-S-3 9.96 DGKE
10 Decreased viability GR00402-S-2 9.96 CYLD DGKE MAPK13 PRKCE
11 Increased mitotic index GR00100-A 8.92 CYLD
12 Increased mitotic index GR00110-A-0 8.92 CYLD MAPK13 PRKCE

MGI Mouse Phenotypes related to Streptococcus Pneumonia:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.17 CTSH CYLD MAPK13 NPAT PRKCE TGM1

Drugs & Therapeutics for Streptococcus Pneumonia

Drugs for Streptococcus Pneumonia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 321)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
2
Methylprednisolone hemisuccinate Approved Phase 4,Phase 2 2921-57-5
3
Mycophenolic acid Approved Phase 4,Phase 2 24280-93-1 446541
4
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 2 302-25-0
5
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
6
Phenytoin Approved, Vet_approved Phase 4 57-41-0 1775
7
Clavulanate Approved, Vet_approved Phase 4,Phase 3,Phase 2 58001-44-8 5280980
8
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 26787-78-0 33613
9 Strawberry Approved Phase 4,Phase 3
10
Zinc Approved, Investigational Phase 4,Phase 3,Not Applicable 7440-66-6 32051
11
Zinc sulfate Approved, Investigational Phase 4,Not Applicable 7733-02-0
12
Azathioprine Approved Phase 4,Phase 2 446-86-6 2265
13
Adalimumab Approved Phase 4 331731-18-1 16219006
14
Mercaptopurine Approved Phase 4 50-44-2 667490
15
Infliximab Approved Phase 4 170277-31-3
16
Tetracycline Approved, Vet_approved Phase 4,Phase 3,Phase 1,Early Phase 1 60-54-8 5353990
17
Ibuprofen Approved Phase 4 15687-27-1 3672
18
Acetaminophen Approved Phase 4,Phase 3 103-90-2 1983
19
Certolizumab pegol Approved Phase 4 428863-50-7
20
Methotrexate Approved Phase 4,Phase 3,Phase 2 1959-05-2, 59-05-2 126941
21
leucovorin Approved Phase 4,Phase 3,Phase 2 58-05-9 6006 143
22
belimumab Approved Phase 4,Phase 2 356547-88-1 5957 10451420
23
Sulfamethoxazole Approved Phase 4,Phase 3 723-46-6 5329
24
Trimethoprim Approved, Vet_approved Phase 4,Phase 3 738-70-5 5578
25
Telithromycin Approved Phase 4 191114-48-4 70789201 5462516
26
Azithromycin Approved Phase 4,Phase 3,Phase 2,Not Applicable 83905-01-5 55185 447043
27
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
28
Cefoxitin Approved Phase 4 35607-66-0 441199
29
Cefotaxime Approved Phase 4 63527-52-6 456256 5742673
30
Moxifloxacin Approved, Investigational Phase 4,Phase 2 354812-41-2, 151096-09-2 152946
31
Norgestimate Approved, Investigational Phase 4,Phase 2 35189-28-7 6540478
32
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2 50-28-2 5757
33
Ethinyl Estradiol Approved Phase 4,Phase 2 57-63-6 5991
34
Polyestradiol phosphate Approved Phase 4,Phase 2 28014-46-2
35
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 2713 9552079
36
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
37
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
38
Levofloxacin Approved, Investigational Phase 4,Phase 2,Phase 1 100986-85-4 149096
39
Ofloxacin Approved Phase 4,Phase 2,Phase 1 82419-36-1 4583
40
Lenalidomide Approved Phase 4,Phase 2 191732-72-6 216326
41
Ceftriaxone Approved Phase 4,Phase 3 73384-59-5 5479530 5361919
42
Ritonavir Approved, Investigational Phase 4,Not Applicable 155213-67-5 392622
43
Lopinavir Approved Phase 4,Not Applicable 192725-17-0 92727
44
Efavirenz Approved, Investigational Phase 4,Phase 3,Phase 2 154598-52-4 64139
45
Albendazole Approved, Vet_approved Phase 4 54965-21-8 2082
46
Bortezomib Approved, Investigational Phase 4,Phase 2 179324-69-7 387447 93860
47 Daratumumab Approved Phase 4 945721-28-8
48
Ixazomib Approved, Investigational Phase 4 1072833-77-2
49
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
50
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 59-30-3 6037

Interventional clinical trials:

(show top 50) (show all 810)
# Name Status NCT ID Phase Drugs
1 7-valent Pneumococcal Conjugated Vaccination Unknown status NCT00885625 Phase 4
2 Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome Unknown status NCT01346007 Phase 4
3 Study on the Efficacy of Phenytoin in the Prophylaxis of Seizures of Patients With Pneumococcal Meningitis at Least 50 Yrs Old. Unknown status NCT01478035 Phase 4 Phenytoin;placebo
4 B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic Individuals Unknown status NCT01846923 Phase 4
5 Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients Unknown status NCT03041051 Phase 4
6 PCV13 + Hepatitis A Vaccine for Adults Unknown status NCT01926860 Phase 4
7 Pneumonia Vaccine in Liver Transplant Recipients: a Booster Strategy Using a Conjugate Vaccine Unknown status NCT00152802 Phase 4
8 Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau Unknown status NCT02953327 Phase 4
9 Polysaccharide Antibody Response Study Unknown status NCT02429531 Phase 4
10 Middle Meatal Bacteriology During Acute Respiratory Infection in Children Unknown status NCT00545961 Phase 4 placebo;amoxicillin clavulanate acid
11 Pertussis (Tdap) Vaccination in Pregnancy Unknown status NCT01698346 Phase 4
12 Influence of BCG on TDaP-IPV Vaccination Unknown status NCT02771782 Phase 4
13 The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine Completed NCT02592486 Phase 4
14 Study Response of 13-valent Conjugate Pneumococcal Vaccine in Patients With End Stage Renal Disease Completed NCT01974817 Phase 4
15 PCV10 Immunogenicity Study Nepal 2015 Completed NCT02385513 Phase 4
16 Targeting of Immune Response After Pneumococcal Vaccination Completed NCT01402245 Phase 4
17 Protection Against Pneumococcal Infection in Children With T1DM Completed NCT01939522 Phase 4
18 Impact and Cost of a Pharmacist Pneumococcal Vaccination Program With PNEUMOVAX® 23 at an Urban Senior Center Completed NCT01944462 Phase 4
19 Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics Completed NCT00836641 Phase 4
20 13 Valent Pneumococcal Conjugate Vaccine - Follow-on Study Completed NCT01095471 Phase 4
21 Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults Completed NCT00744263 Phase 4
22 A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria Completed NCT01193582 Phase 4
23 Community Acquired Pneumonia: Outcome, Quality of Life and Immune Status Completed NCT02141009 Phase 4
24 Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults Completed NCT02062281 Phase 4
25 Pneumococcal Vaccination for Splenectomised Thalassemia Major Patients in Indonesia Completed NCT03095326 Phase 4 Sucrose
26 Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. Completed NCT02124161 Phase 4
27 Humoral Determinants of Immunity to Pneumococcal Infection Completed NCT00304382 Phase 4
28 Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. Completed NCT01193335 Phase 4
29 A Study to Assess the Antibody Response of Healthy Chinese Children Who Have Been Vaccinated Previously With 4-doses of Prevenar (a Pneumococcal Vaccine) as Babies and Toddlers Completed NCT01298544 Phase 4
30 Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children Completed NCT00580684 Phase 4
31 Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease Completed NCT01908283 Phase 4
32 Efficacy Study of Pneumococcal Vaccination in Crohn's Disease Completed NCT01505855 Phase 4 23-valent polysaccharide pneumococcal vaccine
33 Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits Completed NCT02079701 Phase 4
34 The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study Completed NCT03502291 Phase 4
35 Study Evaluating Prevenar Immunogenicity in High Risk Children Completed NCT00581620 Phase 4
36 Influenza Vaccine and Pneumococcal Vaccine Completed NCT02582047 Phase 4
37 PPSV23 Pneumococcal Vaccine in Chronic Obstructive Pulmonary Disease (COPD) Completed NCT01381367 Phase 4 Normal Saline
38 Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis Completed NCT00493324 Phase 4 alefacept;polyvalent pneumococcal vaccine
39 Study of Evaluation Indexes for Antibody Production in Sera After Immunization Completed NCT00964769 Phase 4
40 Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso Completed NCT01577771 Phase 4
41 Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13® Completed NCT01392378 Phase 4 Paracetamol;Ibuprofen;Paracetamol;Ibuprofen
42 A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants. Completed NCT01250756 Phase 4
43 Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate Vaccines Completed NCT00197808 Phase 4
44 Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902) Completed NCT02260882 Phase 4
45 Immunogenicity of 3+1 Versus 2+1 Schedule for PCV7 Completed NCT02040402 Phase 4
46 Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Completed NCT00371878 Phase 4
47 MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine Completed NCT02225327 Phase 4
48 13-valent Pneumococcal Conjugate Vaccine Study in Adults and Children in India Completed NCT02034877 Phase 4
49 Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A and Prophylactic Antipyretic Treatment Completed NCT01235949 Phase 4 Ibuprofen;Paracetamol
50 Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine Completed NCT03552445 Phase 4

Search NIH Clinical Center for Streptococcus Pneumonia

Genetic Tests for Streptococcus Pneumonia

Anatomical Context for Streptococcus Pneumonia

MalaCards organs/tissues related to Streptococcus Pneumonia:

42
Testes, B Cells, Colon, Kidney, Bone, Spleen, Bone Marrow

Publications for Streptococcus Pneumonia

Articles related to Streptococcus Pneumonia:

(show all 42)
# Title Authors Year
1
Rapid Streptococcus Pneumonia Antigen Detection on Postmortem Urine in a Death Due to Pneumococcal Meningitis. ( 30663991 )
2019
2
Biochemical studies of a β-1,4-rhamnoslytransferase from Streptococcus pneumonia serotype 23F. ( 30648163 )
2019
3
Erratum: Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains [Corrigendum]. ( 30655666 )
2019
4
Synthetic avenues towards a tetrasaccharide related to <i>Streptococcus pneumonia</i> of serotype 6A. ( 29977381 )
2018
5
Sacroiliitis and osteomyelitis caused by serotype 3 Streptococcus pneumonia in a previously healthy adult: a case report. ( 30122960 )
2018
6
Insights into the antibacterial mechanism of PEGylated nano-bacitracin A against Streptococcus pneumonia: both penicillin-sensitive and penicillin-resistant strains. ( 30349251 )
2018
7
Selection of DNA aptamers to Streptococcus pneumonia and fabrication of graphene oxide based fluorescent assay. ( 29964028 )
2018
8
Molecular Characterization and Correlation with β-lactam Resistance of Streptococcus pneumonia Isolates in Hangzhou, China. ( 29866221 )
2018
9
Prolonged extracorporeal membrane oxygenation for pediatric necrotizing pneumonia due to Streptococcus pneumonia and influenza H1N1 co-infection: how long should we wait for native lung recovery? ( 29404795 )
2018
10
Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJA. ( 29277475 )
2018
11
Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia-Mediated Pleural Injury in Mice. ( 29073967 )
2017
12
Fatal infection in adults by pneumolysin & autolysin producing, non-vaccine serotype Streptococcus pneumonia. ( 27377510 )
2016
13
Cylindromatosis (CYLD) inhibits Streptococcus pneumonia-induced plasminogen activator inhibitor-1 expression via interacting with TRAF-6. ( 26056944 )
2015
14
Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis. ( 25755670 )
2015
15
Molecular analysis of pbp2b in Streptococcus pneumonia isolated from clinical and normal flora samples. ( 25274412 )
2015
16
Structural and biochemical analyses of the Streptococcus pneumonia L,D-carboxypeptidase DacB. ( 25664738 )
2015
17
The polysaccharide capsule of Streptococcus pneumonia partially impedes MyD88-mediated immunity during pneumonia in mice. ( 25700108 )
2015
18
pspK gene prevalence and characterization of non-typable Streptococcus pneumonia isolates from Asian countries. ( 25750083 )
2015
19
Correction: Host glycan sugar-specific pathways in Streptococcus pneumonia: galactose as a key sugar in colonisation and infection. ( 25928559 )
2015
20
Prevalence of Nasopharyngeal Carriage of Streptococcus pneumonia in Iran: A Meta-Analysis. ( 26411658 )
2015
21
Nasopharyngeal carriage of Streptococcus pneumonia in pneumonia-prone age groups in Semarang, Java Island, Indonesia. ( 24498104 )
2014
22
Attributable healthcare utilization and cost of pneumonia due to drug-resistant streptococcus pneumonia: a cost analysis. ( 24851182 )
2014
23
Frequency of Streptococcus pneumonia and Haemophilus influenza in acute exacerbation of chronic obstructive airway disease and their sensitivity to levofloxacin. ( 24864632 )
2014
24
Streptococcus pneumonia. ( 25412638 )
2014
25
Catalytic mechanism of hyaluronate lyase from Streptococcus pneumonia [corrected] : quantum mechanical/molecular mechanical and density functional theory studies. ( 23944739 )
2013
26
Serotype distribution and antibiotics susceptibility pattern of Streptococcus pneumonia in Iran. ( 24693373 )
2013
27
Endovascular repair of a Streptococcus pneumonia-induced aortitis complicated by an iliacocaval fistula. ( 22956511 )
2012
28
Report on invasive disease and meningitis due to Haemophilus influenzae and Streptococcus pneumonia from the Network for Surveillance of Pneumococcal Disease in the East African Region. ( 19191610 )
2009
29
Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. ( 17412304 )
2007
30
Streptococcus pneumonia endocarditis associated with gastrointestinal malignancy. ( 17523295 )
2007
31
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the DUEL 2 study. ( 15760429 )
2005
32
Serum concentrations of pneumococcal anticapsular antibodies in children with pneumonia associated with Streptococcus pneumonia infection. ( 14557973 )
2003
33
Streptococcus pneumonia YlxR at 1.35 A shows a putative new fold. ( 11679764 )
2001
34
Ceftriaxone treatment failure of meningitis due to penicillin and ceftriaxone resistant streptococcus pneumonia. ( 27704130 )
1998
35
Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae. A comparison with streptococcus pneumonia. ( 8790080 )
1996
36
A household cluster of fulminant group A streptococcus pneumonia associated with toxic shock syndrome-Quebec. ( 8935389 )
1996
37
Analysis of the gene encoding type 12 PspA of Streptococcus pneumonia EF5668. ( 8586190 )
1995
38
Optochin sensitivity is encoded by the atpC gene of the Streptococcus pneumonia atp (F0F1 H(+)-ATPase) operon. ( 8586191 )
1995
39
Fatal Streptococcus pneumonia infection due to hyposplenism. ( 7992772 )
1994
40
Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. ( 2167295 )
1990
41
Spontaneous streptococcus pneumonia peritonitis in a patient with metastatic gastric cancer: a case report and etiologic consideration. ( 870172 )
1977
42
SERUM TREATMENT OF HEMOLYTIC STREPTOCOCCUS PNEUMONIA. ( 16694172 )
1933

Variations for Streptococcus Pneumonia

Expression for Streptococcus Pneumonia

Search GEO for disease gene expression data for Streptococcus Pneumonia.

Pathways for Streptococcus Pneumonia

GO Terms for Streptococcus Pneumonia

Cellular components related to Streptococcus Pneumonia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytosol GO:0005829 9.17 CTSH CYLD DGKE MAPK13 PRKCE TGM1

Biological processes related to Streptococcus Pneumonia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell cycle GO:0007049 9.26 CYLD MAPK13 NPAT PRKCE
2 positive regulation of epithelial cell migration GO:0010634 9.16 CTSH PRKCE
3 nucleotide-binding oligomerization domain containing signaling pathway GO:0070423 8.62 CYLD TRAF6

Molecular functions related to Streptococcus Pneumonia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 transferase activity GO:0016740 9.02 DGKE MAPK13 PRKCE TGM1 TRAF6

Sources for Streptococcus Pneumonia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....